Accordingly, the current study sought to explore for the first time the functional actions and therapeutic potential of the NST/GPR107-system in PCa cells by investigating the direct effects of NST treatment on normal and tumor (PCa and CRPC) cells and the pathophysiological role of endogenous GPR107 in this severe disease. This evidence concerns the gene GPR107 and posterior cortical atrophy.